The "Drug supply & shortages" conference will focus on lessons learned from the coronavirus pandemic and potential changes in Germany's legal framework.
Representatives of Germany's Health Ministry, payers, lawmakers and wholesalers as well experts in generic pricing will discuss on how to prevent bottlenecks and incentivise drug production in Europe.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.